Skip to main content
. 2021 Oct 19;22(20):11260. doi: 10.3390/ijms222011260

Table 1.

IC50 of the drugs.

Drug BEZ235 LY294002 Rapamycin Gefitinib Cisplatin
Category PI3K/mTOR inhibitor PI3K inhibitor mTOR inhibitor EGFR inhibitor Platinum chemotherapy
FaDu *
Parental 50 nM 19.8 μM 0.6 μM 1.0 μM 1.30 μM
200r 850 nM 44.7 μM >10 μM 8.8 μM 3.85 μM
1000r >1500 nM 43.45 μM >10 μM 20 μM 4.59 μM
UMSCC1 *
Parental 16.39 nM 18.14 μM >50 μM 3.85 μM 5.64 μM
200r >500 nM 44.35 μM >50 μM >50 μM 3.12 μM

* The resistant cells were developed by prolonged incubation with 200 nM (200r) or 1000 nM (1000r) BEZ235.